Global Digital Diabetes Management Market is Expected to Register a Healthy CAGR in the Forecast Period of 2019 to 2026

According to Data Bridge Market Research new Market report, global digital diabetes management market will account to an estimated USD 5.4 billion in 2018 growing at a CAGR of 23.95% during the forecast period of 2018 to 2025.

Global Digital Diabetes Management Market

Access Full Report at https://databridgemarketresearch.com/reports/global-digital-diabetes-management-market/

Global Digital Diabetes Management Market

Diabetes management consists of test strip supplies, connected devices, application driven administrations, along with coaching services so that patients can manage their blood sugar level. Diabetes is a disease that is requires being monitor on daily basis and this digital diabetes management devices help the patient to do that. This helps them to avoid damage to their eyes, kidneys, and nerves.

Segmentation: Global Digital Diabetes Management Market

Global digital diabetes management market is segmented on the basis of type, product and services, end- user and geography.

By Type (Wearable Devices, Handheld Devices), Product and Services (Devices, Digital Diabetes Management Apps, Data Management Software and Platforms, Services), End- User (Self/Home Healthcare, Hospitals & Specialty Diabetes Clinics, Academic & Research Institutes), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa)

FACTORS DRIVING GROWTH IN DIGITAL DIABETES MANAGEMENT MARKET

Increasing prevalence of diabetes

In 2017, the estimated prevalence of diabetes among the 20 to 79 age group was 14.8% in the Mexico, which was 13.9 % in Portugal. In Malta it was 13.2% followed by United States and Turkey with 13% and 12.8% respectively. It is expected that this percentage is going to increase.

Global Digital Diabetes Management Market1

Key Market Competitors:

Few of the major competitors currently working in the digital diabetes management market are Medtronic, F. Hoffmann-La Roche Ltd, Dexcom, Inc., Ascensia Diabetes Care Holdings AG., Abbott., B. Braun Melsungen AG, Glooko, LifeScan, Inc., AgaMatrix Inc., Tandem Diabetes Care, Inc., Insulet Corporation, DarioHealth.

Browse Related Reports:

Global Diabetes Pen Market By Indication (Type I Diabetes, Type II Diabetes), By Product Type (Insulin Pens, Insulin Pen Needles), By Type (Disposable, Reusable), By Therapy (Insulin, Glucagon-Like Peptide-1, Growth Hormones), By End Users (Hospitals, Clinics, Home Care Settings), By Geography – Industry Trends and Forecast to 2024

https://databridgemarketresearch.com/reports/global-diabetes-pen-market/

Global Diabetes Treatments Market, By Product (Insulin, Oral Hypoglycemic Drugs, Non-Insulin Injectable Drugs), Devices( Blood Glucose Meters and Strips, Continuous Glucose Monitors (CGMs), Flash Glucose Monitoring Device, Injection Pens, Insulin Pumps, Automated Insulin Delivery Systems), End User (Hospital, Personal Use, Clinic), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends & Forecast to 2026

https://databridgemarketresearch.com/reports/global-diabetes-treatments-market/